España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Comments
Close menu
Loading...
Dare Bioscience
DARE
NASDAQ
Watchlist
Leave a Comment
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$3.69
0.15
4.24%
At Close: -
$3.60
-0.09
-2.44%
After Hours: Jul 19, 6:03 PM EDT
15 minutes delayed
Get Report
Comment
Dare Bioscience (DARE) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Dare Bioscience (NASDAQ:DARE) Stock
Dare Bioscience Stock (NASDAQ: DARE)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, July 19, 2024
Daré Bioscience Regains Compliance With Nasda...
Benzinga Newsdesk
Monday, July 01, 2024
Trading Halt: Halt status updated at 8:55:00 ...
Benzinga Newsdesk
Friday, June 28, 2024
Trading Halt: Halted at 7:50:00 p.m. ET - Tra...
Benzinga Newsdesk
Thursday, June 27, 2024
Dare Bioscience shares are trading lower afte...
Benzinga Newsdesk
Daré Bioscience Announces 1-For-12 Reverse St...
Benzinga Newsdesk
Monday, June 24, 2024
Daré Bioscience Announces Publication Of Phas...
Benzinga Newsdesk
Thursday, May 30, 2024
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
Tuesday, May 21, 2024
Why James Hardie Industries Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
Friday, May 17, 2024
Bayer Highlights Detailed Data From Twin Late-Stage Trials On Experimental Menopause Candidate, Seeks Regulatory Approval
Vandana Singh
Wednesday, May 15, 2024
HC Wainwright & Co. Reiterates Buy on Dare Bi...
Benzinga Newsdesk
Dare Bioscience shares are trading higher aft...
Benzinga Newsdesk
Brookline Capital Upgrades Dare Bioscience to...
Benzinga Newsdesk
Tuesday, May 14, 2024
Dare Bioscience Q1 EPS $(0.07) Misses $(0.06)...
Benzinga Newsdesk
Friday, May 10, 2024
Dare Bioscience Files For Common Stock Offeri...
Benzinga Newsdesk
Thursday, May 02, 2024
Daré Bioscience Selected As A Member Of ARPA-...
Benzinga Newsdesk
Wednesday, May 01, 2024
HC Wainwright & Co. Reiterates Buy on Dare Bi...
Benzinga Newsdesk
Tuesday, April 30, 2024
Why H&E Equipment Services Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
Dare Bioscience shares are trading higher aft...
Benzinga Newsdesk
Xoma Has Acquired An Economic Interest In Thr...
Benzinga Newsdesk
Thursday, April 25, 2024
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
Wednesday, April 24, 2024
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
Tuesday, April 23, 2024
Daré Bioscience To Receive $1M Installment Un...
Benzinga Newsdesk
Wednesday, April 17, 2024
Dare Bioscience shares are trading lower afte...
Benzinga Newsdesk
Brookline Capital Downgrades Dare Bioscience ...
Benzinga Newsdesk
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
Thursday, April 11, 2024
Daré Bioscience Announces Publication In Cont...
Benzinga Newsdesk
Monday, April 01, 2024
HC Wainwright & Co. Reiterates Buy on Dare Bi...
Benzinga Newsdesk
Thursday, March 28, 2024
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
Dare Bioscience Q4 EPS $(0.06) Beats $(0.10) ...
Benzinga Newsdesk
Recap: Dare Bioscience Q4 Earnings
Benzinga Insights
Daré Bioscience Reported FY23 Revenue of $2.8...
Benzinga Newsdesk
Earnings Scheduled For March 28, 2024
Benzinga Insights
Wednesday, March 27, 2024
Dare Bioscience Earnings Preview
Benzinga Insights
Tuesday, March 26, 2024
'Supreme Court Unlikely To Limit Access To Ab...
Benzinga Newsdesk
Monday, March 04, 2024
'France becomes first country to explicitly e...
Benzinga Newsdesk
Wednesday, February 21, 2024
First Lady Jill Biden Unveils $100M In Federal Funding To Support R&D - Watch Out for These Women Health Stocks
Vandana Singh
Wednesday, January 31, 2024
Daré Bioscience Announces End-of-Phase 2 Mee...
Benzinga Newsdesk
Friday, January 26, 2024
Daré Bioscience CFO Lisa Walters-Hoffert Ret...
Benzinga Newsdesk
Wednesday, January 17, 2024
Daré Bioscience Announces Grant From The Bill...
Benzinga Newsdesk
Thursday, January 04, 2024
Daré Bioscience's DARE-LARC1 Platform Techno...
Benzinga Newsdesk
Tuesday, December 26, 2023
Daré Bioscience Secures $12M In Royalty-Backed Investment Structure; Daré Issued To The Investor A 5-Year Warrant To Purchase An Aggregate Of 5M Shares Of Daré's Common Stock At An Exercise Price Of $0.3467 Per Share
Happy Mohamed
Wednesday, December 20, 2023
Daré Bioscience Highlights Efficacy Data From Treatment Candidate For Painful Menstruation
Vandana Singh
Daré Bioscience Announces Topline Pharmacoki...
Benzinga Newsdesk
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
Wednesday, December 13, 2023
Daré Bioscience Announces Funding Award Notic...
Benzinga Newsdesk
Thursday, December 07, 2023
FDA Gives Nod To Daré Bioscience's Trial Of Non-Hormonal Treatment For Dyspareunia, Seeks Additional Funding
Vandana Singh
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
Daré Bioscience Announces FDA Clearance Of In...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch